Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.35B | 14.81B | 14.06B | 12.68B | 11.62B | Gross Profit |
8.53B | 8.08B | 7.32B | 6.98B | 6.49B | EBIT |
2.59B | 3.19B | 2.60B | 2.89B | 2.48B | EBITDA |
3.38B | 3.97B | 3.58B | 3.74B | 2.85B | Net Income Common Stockholders |
1.44B | 2.18B | 1.44B | 2.15B | 1.32B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
510.00M | 267.00M | 535.00M | 567.00M | 240.00M | Total Assets |
53.43B | 52.13B | 51.84B | 50.60B | 49.78B | Total Debt |
17.27B | 14.82B | 11.97B | 11.88B | 13.49B | Net Debt |
16.76B | 14.56B | 11.43B | 11.31B | 13.25B | Total Liabilities |
29.19B | 26.45B | 26.71B | 25.63B | 25.95B | Stockholders Equity |
24.24B | 25.68B | 25.13B | 24.97B | 23.83B |
Cash Flow | Free Cash Flow | |||
1.66B | 848.00M | 2.46B | 2.42B | 1.94B | Operating Cash Flow |
2.22B | 1.33B | 2.84B | 2.87B | 2.46B | Investing Cash Flow |
-1.61B | -784.00M | -1.14B | 210.00M | -316.00M | Financing Cash Flow |
-223.00M | -832.00M | -1.73B | -2.76B | -1.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $308.40B | 28.71 | 40.98% | 2.76% | 1.08% | 0.28% | |
79 Outperform | $41.26B | 26.85 | 17.43% | 2.38% | 11.73% | -15.34% | |
76 Outperform | $58.04B | 40.11 | 21.27% | ― | 4.94% | -4.13% | |
75 Outperform | $183.11B | 19.64 | 50.06% | 4.06% | -0.38% | 2.23% | |
74 Outperform | $46.74B | 31.17 | 6.13% | 2.66% | 3.95% | -28.73% | |
66 Neutral | $9.98B | 18.21 | 36.83% | 0.67% | 3.21% | 31.83% | |
64 Neutral | $8.88B | 14.97 | 4.63% | 174.27% | 3.67% | 4.40% |
On April 21, 2025, Keurig Dr Pepper‘s Board of Directors approved the transition of Robert Gamgort from Executive Chairman to non-employee Chairman, effective April 24, 2025. The Board also expanded to ten directors, appointing Michael Van de Ven and Lawson Whiting as independent members, effective the same date. These appointments are part of the company’s strategic governance adjustments, with Van de Ven joining the Audit and Finance Committee and Whiting joining the Remuneration and Nomination Committee.
Spark’s Take on KDP Stock
According to Spark, TipRanks’ AI Analyst, KDP is a Outperform.
Keurig Dr Pepper’s overall stock score reflects its robust financial performance and positive market momentum. The company’s strong guidance and strategic initiatives, including the new credit agreement, bolster its outlook. However, the high P/E ratio suggests that the stock might be overvalued, and challenges in specific segments could pose risks.
To see Spark’s full report on KDP stock, click here.
On March 31, 2025, Keurig Dr Pepper Inc. entered into a new $4 billion unsecured revolving credit agreement with JPMorgan Chase Bank, which will mature on March 31, 2030. This agreement, replacing a previous one from February 2022, is intended for general corporate purposes and working capital, potentially enhancing the company’s financial flexibility and operational capacity.
On February 28, 2025, Keurig Dr Pepper Inc. experienced significant changes in its board of directors as three members affiliated with JAB BevCo B.V. resigned, reducing the board size from eleven to eight. This coincided with the completion of a public secondary offering by the Selling Stockholder, resulting in gross proceeds of approximately $2.7 billion, although the company did not receive any proceeds from this sale.